Blog

Current and Emerging Therapies for Patients With Multiple Myeloma

November 5, 2020

Multiple myeloma (MM) is a malignant disease of the bone marrow characterized by clonal expansion of plasma cells (1, 2)....

Blog

Improving Informed Consent in Clinical Trials

October 16, 2020

Does more information mean better knowledge? Authors: Ruth Cohen PhD, Regulatory Affairs Associate, CATO SMS Recruitment and retainment of patients...

Blog

New FDA Guidances for August 2020 and Upcoming Advisory Committee Meetings

September 3, 2020

By Dieanira Erudaitius, PhD, RAC, Regulatory Scientist, Regulatory Affairs at CATO SMS    Special Interest Guidances/Information Date Posted Principles for...

Blog

New FDA Guidances for July 2020 and Upcoming Advisory Committee Meetings

August 5, 2020

By Joshua Taylor, PhD, RAC, Director – Regulatory Affairs at CATO SMS Special Interest Guidances/Information Date Posted Pediatric Study Plans:...

Blog

Immuno-oncology updates in the virtual era – ASCO 2020

July 27, 2020

This year’s ASCO Annual Scientific Meeting took place between May 29-31, with the Education Program planned for August 8-10. Unlike previous...

Blog

New FDA Guidances for June 2020 and Upcoming Advisory Committee Meetings

July 5, 2020

By Sheila Plant, PhD, MHS, RAC, Senior Director, Regulatory Affairs at CATO SMS    Special Interest Guidances/Information Date Posted Development...

Blog

Are you ready for the new European clinical trial regulation?

June 29, 2020

The new European Clinical Trial Regulation (ECTR) will replace the 2001/20/EC Directive, the directive that currently describes how clinical trials should be conducted in...

Blog

Clinical Research Regulation in the Netherlands

June 15, 2020

Before the first human subject receives an investigational medicinal product, the clinical trial has to be approved according to applicable...

Blog

What’s New Health Canada?

May 7, 2020

By Alejandra Gomez Perez, M.Sc., Regulatory Affairs Associate What’s New in: Therapeutic Products Directorate: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/what-new-drug-products-health-canada.html Biologics and Genetic Therapies Directorate:...

Blog

Consideration for ongoing clinical trials: Ensuring Participant Safety and Adapting New Processes during COVID‑19 Pandemic

April 29, 2020

By Ashley Henderson, PhD, CATO SMS Scientist 1.0 INTRODUCTION The COVID‑19 pandemic has added an unprecedented set of challenges to...